BCKDE Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BCKDE monoclonal antibodies for investigating branched-chain keto acid dehydrogenase (BCKDE) in various biological processes. BCKDE monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BCKDE is a critical enzyme complex involved in the catabolism of branched-chain amino acids, which are essential for protein synthesis and energy production. Dysregulation of BCKDE activity has been linked to metabolic disorders, including maple syrup urine disease and other conditions affecting amino acid metabolism. Understanding the function and regulation of BCKDE is vital for developing therapeutic strategies for metabolic diseases. BCKDE monoclonal antibodies enable precise detection and quantification of BCKDE expression levels across different tissue types. Researchers can utilize BCKDE monoclonal antibodies to study protein-protein interactions and cellular localization patterns. Advanced research techniques incorporating BCKDE monoclonal antibodies help reveal new insights about amino acid metabolism pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of metabolic diseases and potential therapeutic interventions.